Pharmaniaga Berhad (KLSE:PHARMA)
0.7400
-0.0200 (-2.63%)
At close: Nov 20, 2026
Pharmaniaga Berhad Revenue
Pharmaniaga Berhad had revenue of 1.01B MYR in the quarter ending September 30, 2026, with 0.72% growth. This brings the company's total for the last twelve months to 4.17B, up 6.55% year-over-year. In the year 2025, Pharmaniaga Berhad had annual revenue of 3.93B with 4.48% growth. That makes Pharmaniaga Berhad the 7,591st largest company in the world by revenue and 66th in Malaysia.
Revenue (ttm)
4.17B
Revenue Growth
+6.55%
P/S Ratio
0.23
Revenue / Employee
1.19M
Employees
3,502
Market Cap
970.44M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Pharmaniaga Berhad breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.93B | 168.27M | 4.48% |
| Dec 31, 2024 | 3.76B | 355.00M | 10.43% |
| Dec 31, 2023 | 3.40B | -76.45M | -2.20% |
| Dec 31, 2022 | 3.48B | -1.33B | -27.71% |
| Dec 31, 2021 | 4.82B | 2.09B | 76.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Capital A Berhad | 2.61B |
| Duopharma Biotech Berhad | 916.98M |
| Crescendo Corporation Berhad | 817.39M |
| JCY International Berhad | 589.17M |
| Master Tec Group Berhad | 556.02M |
| Lim Seong Hai Capital Berhad | 500.28M |
| Prolintas Infra Business Trust | 348.11M |
| CTOS Digital Berhad | 344.01M |